Abstract:The molecular mechanisms leading to neurodegeneration in Parkinson disease (PD) remain elusive, although many lines of evidence have indicated that alpha-synuclein and DJ-1, two critical proteins in PD pathogenesis, interact with each other functionally. The investigation on whether alpha-synuclein directly interacts with DJ-1 has been controversial. In the current study, we analyzed proteins associated with alpha-synuclein and/or DJ-1 with a robust proteomics technique called stable isotope labeling by amino acids in cell culture (SILAC) in dopaminergic MES cells exposed to rotenone versus controls. We identified 324 and 306 proteins in the alpha-synuclein- and DJ-1-associated protein complexes, respectively. Among alpha-synuclein- associated proteins, 141 proteins displayed significant changes in the relative abundance (increase or decrease) after rotenone treatment; among DJ-1-associated proteins, 119 proteins displayed significant changes in the relative abundance after rotenone treatment. Although no direct interaction was observed between alpha-synuclein and DJ-1, whether analyzed by affinity purification followed by mass spectrometry or subsequent direct co-immunoprecipitation, 144 proteins were seen in association with both alpha-synuclein and DJ-1. Of those, 114 proteins displayed significant changes in the relative abundance in the complexes associated with alpha-synuclein, DJ-1, or both after rotenone treatment. A subset of these proteins (mortalin, nucleolin, grp94, calnexin, and clathrin) was further validated for their association with both alpha-synuclein and DJ-1 using confocal microscopy, Western blot, and/or immunoprecipitation. Thus, we not only confirmed that there was no direct interaction between alpha-synuclein and DJ-1 but also, for the first time, report these five novel proteins to be associating with both alpha-synuclein and DJ-1. Further characterization of these docking proteins will likely shed more light on the mechanisms by which DJ-1 modulates the function of alpha-synuclein, and vice versa, in the setting of PD.

A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.

Network Integration and Protein Structural Binding Analysis of Neurodegeneration-Related Interactome.

Protein-protein Interaction Network with Machine Learning Models and Multiomics Data Reveal Potential Neurodegenerative Disease-Related Proteins

Research on Screening and Identification of Proteins Interacting with Ataxin-3.

Towards Identification of Human Disease Phenotype-Genotype Association via a Network-Module Based Method

Identification of Novel Proteins Associated with Both α-Synuclein and DJ-1

Identification of novel proteins interacting with both α-synuclein and DJ-1

Identification of novel proteins associated with both alpha-synuclein and DJ-1.

Widespread Macromolecular Interaction Perturbations in Human Genetic Disorders

Genome-Scale Networks Link Neurodegenerative Disease Genes to α-Synuclein through Specific Molecular Pathways

Protein Interaction Network Biology in Neuroscience

Rigidity and flexibility in protein-protein interaction networks: a case study on neuromuscular disorders

The Essential And Downstream Common Proteins Of Amyotrophic Lateral Sclerosis: A Protein-Protein Interaction Network Analysis

Comprehensive Characterization of Protein-Protein Interaction Network Perturbations by Human Disease Mutations

Construction of Protein-Protein Interaction Network of Parkinson's Disease Associated Proteins

Overarching pathomechanisms in inherited peripheral neuropathies, spastic paraplegias, and cerebellar ataxias

Spinal cord phosphoproteome of a SCA2/ALS13 mouse model reveals alteration of ATXN2-N-term SH3-actin interactome and of autophagy via WNK1-MYO6-OPTN-SQSTM1

Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways

Edgetic Perturbation Models of Human Inherited Disorders

Exome Sequencing Links Corticospinal Motor Neuron Disease to Common Neurodegenerative Disorders

Cerebellum-Enriched Protein Inpp5a Contributes To Selective Neuropathology In Mouse Model Of Spinocerebellar Ataxias Type 17